Elligo Health Research Names CDISC Founder as New Scientific Innovation Officer

Rebecca Kush, Ph.D., Elligo's new scientific innovation officer (Photo: Business Wire).

Rebecca Kush, Ph.D., Elligo's new scientific innovation officer (Photo: Business Wire).

???pagination.previous??? ???pagination.next???

AUSTIN, Texas--()--Elligo Health Research, a leading clinical research infrastructure (CRI) provider that brings together sponsors, clinicians, patients and CROs to improve clinical trial access and efficiency, has hired Rebecca Kush, Ph.D., as scientific innovation officer.

Kush is the founder and was the president and CEO of the Clinical Data Interchange Standards Consortium (CDISC) where she spent 20 years leading the development of global clinical research data standards to streamline clinical research. While there, she had an integral role in the development of methods and processes to link research and health care.

Kush’s extensive research and process expertise will support Elligo’s unique Goes Direct™ approach, using electronic health record data to identify patients for research studies, then providing these patients’ physicians with the personnel, procedures, technology and infrastructure necessary to conduct the study in their own clinics.

Kush earned a doctorate in physiology and pharmacology from the University of California, San Diego, School of Medicine and also has worked for the U.S. National Institutes of Health, academia, a global contract research organization and U.S. and Japanese pharmaceutical companies during her career.

“This anchors an important area of growth for Elligo,” said John Potthoff, Ph.D., co-founder and CEO of Elligo Health Research. “Kush’s unrivaled experience in data standards will have an immediate impact — widening access to data for trial sponsors from source to submission.”

To learn more about Elligo Health Research’s work in clinical research, visit elligodirect.com.

About Elligo:
Elligo Health Research offers the only platform that brings clinical research to the clinic, accelerating the development of new pharmaceutical, biotechnology and medical device products and therapies. Elligo Goes Direct™ with an approach that uses electronic health records and other health data to identify real-world patients and physicians for participation in clinical studies. It is our mission to support health care providers by providing personnel, procedures, technology and infrastructure for clinical research, enabling patients to participate in research while remaining under the care of their own trusted physician. Learn more at elligodirect.com.

Contacts

SCORR Marketing
Lea Studer, 308-237-5567
lea@scorrmarketing.com

Release Summary

Elligo Health Research has hired Rebecca Kush, Ph.D., as scientific innovation officer.

Social Media Profiles

Contacts

SCORR Marketing
Lea Studer, 308-237-5567
lea@scorrmarketing.com